Insider Deck research · News

TWST stock news · Twist Bioscience Corporation

Latest Twist Bioscience Corporation (TWST) stock news, headlines, and research context on Insider Deck. Sector: Healthcare. Industry: Diagnostics & Research. Market cap $7.2B.

News desk

Twist Bioscience Corporation wire

Read the briefing on Insider Deck — headline, teaser, and desk context stay here. Publisher sites remain optional for the full longform.

9 on the wireUpdated within the hour

Business Wire·Wed, Aug 5, 3:45 AM

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., August 05, 2026--Twist Bioscience Corporation (Nasdaq: TWST) ("Twist"), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its common stock at a price to the public of $96.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Twist. The gross proceeds to Twist from the offering, before deducting the underwriting discounts and commission

Insider Deck desk note

Last$115.01
Day+15.65%
SymbolTWST

Cross-check the tape against filings and ownership — the headline is the spark; the desk is the research.

Company KPIsShareholdersBuys vs Sells
Continue on Business Wire

Frequently asked questions

What is the latest news on TWST?

The TWST news desk aggregates recent headlines with research context for Twist Bioscience Corporation (Healthcare).

Where can I research TWST on Insider Deck?

Twist Bioscience Corporation (TWST) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.